151 related articles for article (PubMed ID: 24728301)
21. Down-regulation of lncRNA PCGEM1 inhibits cervical carcinoma by modulating the miR-642a-5p/LGMN axis.
Liu Y; Wang Y; Shen X; Chen C; Ni H; Sheng N; Hua M; Wu Y
Exp Mol Pathol; 2020 Dec; 117():104561. PubMed ID: 33121976
[TBL] [Abstract][Full Text] [Related]
22. CXCR4 positive cells from Lewis lung carcinoma cell line have cancer metastatic stem cell characteristics.
Nian WQ; Chen FL; Ao XJ; Chen ZT
Mol Cell Biochem; 2011 Sep; 355(1-2):241-8. PubMed ID: 21553023
[TBL] [Abstract][Full Text] [Related]
23. [RNAi-mediated Silencing of CXCR4 Inhibits the Adhesion, Invasion and Tumorigenicity of Acute Monocytic Leukemic Cell Line SHI-1].
Fu L; Li ZJ; Yang GL; Zheng JF; Shi QZ; Chen SJ; Li J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1286-91. PubMed ID: 26524024
[TBL] [Abstract][Full Text] [Related]
24. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases.
Zeelenberg IS; Ruuls-Van Stalle L; Roos E
Cancer Res; 2003 Jul; 63(13):3833-9. PubMed ID: 12839981
[TBL] [Abstract][Full Text] [Related]
25. Silencing of bach1 gene by small interfering RNA-mediation regulates invasive and expression level of miR-203, miR-145, matrix metalloproteinase-9, and CXCR4 receptor in MDA-MB-468 breast cancer cells.
Mohammadzadeh R; Saeid Harouyan M; Ale Taha SM
Tumour Biol; 2017 Mar; 39(3):1010428317695925. PubMed ID: 28349828
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro.
Li JK; Yu L; Shen Y; Zhou LS; Wang YC; Zhang JH
World J Gastroenterol; 2008 Apr; 14(15):2308-13. PubMed ID: 18416455
[TBL] [Abstract][Full Text] [Related]
27. CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways.
Sobolik T; Su YJ; Wells S; Ayers GD; Cook RS; Richmond A
Mol Biol Cell; 2014 Mar; 25(5):566-82. PubMed ID: 24403602
[TBL] [Abstract][Full Text] [Related]
28. CXCR-4 knockdown by small interfering RNA inhibits cell proliferation and invasion of oral squamous cell carcinoma cells.
Hong JS; Pai HK; Hong KO; Kim MA; Kim JH; Lee JI; Hong SP; Hong SD
J Oral Pathol Med; 2009 Feb; 38(2):214-9. PubMed ID: 18624931
[TBL] [Abstract][Full Text] [Related]
29. CRISPR/Cas9-mediated genome engineering of CXCR4 decreases the malignancy of hepatocellular carcinoma cells in vitro and in vivo.
Wang X; Zhang W; Ding Y; Guo X; Yuan Y; Li D
Oncol Rep; 2017 Jun; 37(6):3565-3571. PubMed ID: 28498420
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.
Douglass S; Meeson AP; Overbeck-Zubrzycka D; Brain JG; Bennett MR; Lamb CA; Lennard TW; Browell D; Ali S; Kirby JA
J Pathol; 2014 Sep; 234(1):74-85. PubMed ID: 24870556
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
[TBL] [Abstract][Full Text] [Related]
32. SDF-1α upregulation of MMP-2 is mediated by p38 MAPK signaling in pancreatic cancer cell lines.
Pan F; Ma S; Cao W; Liu H; Chen F; Chen X; Shi R
Mol Biol Rep; 2013 Jul; 40(7):4139-46. PubMed ID: 23712777
[TBL] [Abstract][Full Text] [Related]
33. Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of Prrx1.
Tang Y; Lu Y; Chen Y; Luo L; Cai L; Peng B; Huang W; Liao H; Zhao L; Pan M
J Exp Clin Cancer Res; 2019 Nov; 38(1):473. PubMed ID: 31752959
[TBL] [Abstract][Full Text] [Related]
34. Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro.
Liu Y; Ren CC; Yang L; Xu YM; Chen YN
J Cell Physiol; 2019 Apr; 234(4):3897-3909. PubMed ID: 30191987
[TBL] [Abstract][Full Text] [Related]
35. CXCR4 and PTEN are involved in the anti-metastatic regulation of anethole in DU145 prostate cancer cells.
Rhee YH; Chung PS; Kim SH; Ahn JC
Biochem Biophys Res Commun; 2014 May; 447(4):557-62. PubMed ID: 24525130
[TBL] [Abstract][Full Text] [Related]
36. AGTR1 promotes lymph node metastasis in breast cancer by upregulating CXCR4/SDF-1α and inducing cell migration and invasion.
Ma Y; Xia Z; Ye C; Lu C; Zhou S; Pan J; Liu C; Zhang J; Liu T; Hu T; Xie L; Wu G; Zhao Y
Aging (Albany NY); 2019 Jun; 11(12):3969-3992. PubMed ID: 31219799
[TBL] [Abstract][Full Text] [Related]
37. Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis.
Hernandez L; Magalhaes MA; Coniglio SJ; Condeelis JS; Segall JE
Breast Cancer Res; 2011; 13(6):R128. PubMed ID: 22152016
[TBL] [Abstract][Full Text] [Related]
38. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo.
Lapteva N; Yang AG; Sanders DE; Strube RW; Chen SY
Cancer Gene Ther; 2005 Jan; 12(1):84-9. PubMed ID: 15472715
[TBL] [Abstract][Full Text] [Related]
39. CXCL12 is a key regulator in tumor microenvironment of cervical cancer: an in vitro study.
Yadav SS; Prasad SB; Prasad CB; Pandey LK; Pradhan S; Singh S; Narayan G
Clin Exp Metastasis; 2016 Jun; 33(5):431-9. PubMed ID: 26970955
[TBL] [Abstract][Full Text] [Related]
40. The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma.
Hu J; Deng X; Bian X; Li G; Tong Y; Li Y; Wang Q; Xin R; He X; Zhou G; Xie P; Li Y; Wang JM; Cao Y
Clin Cancer Res; 2005 Jul; 11(13):4658-65. PubMed ID: 16000558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
